Dr. Gerrit Hauck has been appointed as chief technology officer and member of the management committee at Basilea Pharmaceutica Ltd., effective May 1. He will succeed Dr. Günter Ditzinger who will take on new responsibilities at Basilea. Hauck joins Basilea from Sanofi, where he was cluster head synthetic molecules and a member of Sanofi's research stage gate committee. Basilea has also announced that Dr. Josef Künzle, head of global quality management and a member of the extended management committee, will retire on Oct. 31. He will be succeeded by Dr. Anne Stehlin, who joins Basilea from Novartis AG where she was global head of product quality lifecycle management. She will initially serve as Basilea's deputy head of global quality management until Oct. 31.
Joanna Shields has been appointed group CEO at the private artificial intelligence company BenevolentAI with immediate effect. Shields most recently served as the UK Minister for Internet Security & Safety, a special advisor to the UK government on the digital economy, and Chair & CEO of TechCityUK
